protocatechuic acid has been researched along with Brain Disorders in 2 studies
protocatechuic acid: RN given refers to parent cpd; structure
3,4-dihydroxybenzoic acid : A dihydroxybenzoic acid in which the hydroxy groups are located at positions 3 and 4.
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, one consistent result of these studies is that the systemic bioavailability of anthocyanins, including cyanidin 3-O-glucopyranoside (Cy-3G), is very poor." | 1.34 | Neuroprotective effects of anthocyanins and their in vivo metabolites in SH-SY5Y cells. ( Angeloni, C; Cantelli-Forti, G; Hrelia, P; Hrelia, S; Marchesi, A; Morroni, F; Tarozzi, A, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelrahman, RS | 1 |
| El-Tanbouly, GS | 1 |
| Tarozzi, A | 1 |
| Morroni, F | 1 |
| Hrelia, S | 1 |
| Angeloni, C | 1 |
| Marchesi, A | 1 |
| Cantelli-Forti, G | 1 |
| Hrelia, P | 1 |
2 other studies available for protocatechuic acid and Brain Disorders
| Article | Year |
|---|---|
Protocatechuic acid protects against thioacetamide-induced chronic liver injury and encephalopathy in mice via modulating mTOR, p53 and the IL-6/ IL-17/ IL-23 immunoinflammatory pathway.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Brain Diseases; Hydroxybenzoates; Interleukin-17; I | 2022 |
Neuroprotective effects of anthocyanins and their in vivo metabolites in SH-SY5Y cells.
Topics: Anthocyanins; Antioxidants; Apoptosis; Brain Diseases; Cell Line, Tumor; Cytosol; Drug Evaluation, P | 2007 |